Journal of Genetic Medicine

  • 제17권2호
  • /
  • Pages.92-96
  • /
  • 2020
  • /
  • 1226-1769(pISSN)
  • /
  • 2383-8442(eISSN)
대한의학유전학회 (Korean Society of Medical Genetics and Genomics)
권호 표지
DOI QR코드

DOI QR Code

Hypotonia, Ataxia, and Delayed Development Syndrome caused by the EBF3 mutation in a Korean boy with muscle hypotonia

  • Kim, Tae-Gyeong (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Yoon-Ha (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Ye-Na (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Min-Ji (Genome Research Center for Birth Defects and Genetic Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seo, Go Hun (Billion, Inc.) ;
  • Lee, Beom Hee (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2020.09.04
  • 심사 : 2020.10.07
  • 발행 : 2020.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Hypotonia, Ataxia, and Delayed Development Syndrome (HADDS) is an autosomal-dominant, extremely rare neurodevelopmental disorder caused by the heterozygous EBF3 gene mutation. EBF3 is located on chromosome 10q26.3 and acts as a transcription factor that regulates neurogenesis and differentiation. This syndrome is characterized by dysmorphism, cerebellar hypoplasia, urogenital anomaly, hypotonia, ataxia, intellectual deficit, and speech delay. The current report describes a 3-year-old Korean male carrying a de novo EBF3 mutation, c.589A>G (p.Asn197Asp), which was identified by whole exome sequencing. He manifested facial dysmorphism, hypotonia, strabismus, vermis hypoplasia, and urogenital anomalies, including vesicoureteral reflux, cryptorchidism, and areflexic bladder. This is the first report of a case of HADDS cause by an EBF3 mutation in the Korean population.

키워드

참고문헌

  1. Chao HT, Davids M, Burke E, Pappas JG, Rosenfeld JA, McCarty AJ, et al. A syndromic neurodevelopmental disorder caused by de novo variants in EBF3. Am J Hum Genet 2017;100:128-37. https://doi.org/10.1016/j.ajhg.2016.11.018
  2. Blackburn PR, Barnett SS, Zimmermann MT, Cousin MA, Kaiwar C, Pinto E Vairo F, et al. Novel de novo variant in EBF3 is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases. Cold Spring Harb Mol Case Stud 2017;3:a001743. https://doi.org/10.1101/mcs.a001743
  3. Harms FL, Girisha KM, Hardigan AA, Kortum F, Shukla A, Alawi M, et al. Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia, and facial dysmorphism. Am J Hum Genet 2017;100:117-27. https://doi.org/10.1016/j.ajhg.2016.11.012
  4. Sleven H, Welsh SJ, Yu J, Churchill MEA, Wright CF, Henderson A, et al. De novo mutations in EBF3 cause a neurodevelopmental syndrome. Am J Hum Genet 2017;100:138-50. https://doi.org/10.1016/j.ajhg.2016.11.020
  5. Tanaka AJ, Cho MT, Willaert R, Retterer K, Zarate YA, Bosanko K, et al. De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism. Cold Spring Harb Mol Case Stud 2017;3:a002097. https://doi.org/10.1101/mcs.a002097
  6. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
  7. Lin S, Zhou Y, Fang Q, Wu J, Zhang Z, Ji Y, et al. Chromosome 10q26 deletion syndrome: two new cases and a review of the literature. Mol Med Rep 2016;14:5134-40. https://doi.org/10.3892/mmr.2016.5864
  8. Wang SS, Lewcock JW, Feinstein P, Mombaerts P, Reed RR. Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection. Development 2004;131:1377-88. https://doi.org/10.1242/dev.01009
  9. Chiara F, Badaloni A, Croci L, Yeh ML, Cariboni A, Hoerder-Suabedissen A, et al. Early B-cell factors 2 and 3 (EBF2/3) regulate early migration of Cajal-Retzius cells from the cortical hem. Dev Biol 2012;365:277-89. https://doi.org/10.1016/j.ydbio.2012.02.034
  10. Harding SD, Armit C, Armstrong J, Brennan J, Cheng Y, Haggarty B, et al. The GUDMAP database--an online resource for genitourinary research. Development 2011;138:2845-53. https://doi.org/10.1242/dev.063594
  11. Siponen MI, Wisniewska M, Lehtio L, Johansson I, Svensson L, Raszewski G, et al. Structural determination of functional domains in early B-cell factor (EBF) family of transcription factors reveals similarities to Rel DNA-binding proteins and a novel dimerization motif. J Biol Chem 2010;285:25875-9. https://doi.org/10.1074/jbc.C110.150482